![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Gravholt C.H.
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.2, Iss.6, 2002-01, pp. : 401-413
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Aspects of the treatment of Turner syndrome
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment strategies for Zollinger–Ellison syndrome
By Wilcox C Mel Hirschowitz Basil I
Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 7, 2009-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 4, 2011-12 ,pp. :